Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy - Vaccibody.com
2578
post-template-default,single,single-post,postid-2578,single-format-standard,bridge-core-2.4.3,qode-page-transition-enabled,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-25.7,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.6.0,vc_responsive

December 10, 2020 Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy

Posted at 10:26h in Uncategorized by

Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy.

View press release (PDF)